OP
RVMD icon

Oslo Pensjonsforsikring’s Revolution Medicines RVMD Stock Holding History

Oslo Pensjonsforsikring’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Hold
600
– – 0.01% 400
2026
Q1 		$58.4K Buy
+600
New +$60.6K 0.01% 431

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Oslo Pensjonsforsikring's RVMD Position: Q2 2026 in Review

Oslo Pensjonsforsikring held its Revolution Medicines (RVMD) position steady in Q2 2026 at 600 shares worth $112K. The position accounts for 0.01% of the portfolio, ranked #400.

Oslo Pensjonsforsikring first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Oslo Pensjonsforsikring held 600 shares of Revolution Medicines worth $112K as of Q2 2026.
  • Oslo Pensjonsforsikring left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 0.01% of Oslo Pensjonsforsikring's portfolio in Q2 2026, its #400 holding.
  • Oslo Pensjonsforsikring first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Oslo Pensjonsforsikring's 13F filing for Q2 2026, filed 31 Jul 2026.